182 related articles for article (PubMed ID: 21540187)
1. Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling.
Bäumer N; Tickenbrock L; Tschanter P; Lohmeyer L; Diederichs S; Bäumer S; Skryabin BV; Zhang F; Agrawal-Singh S; Köhler G; Berdel WE; Serve H; Koschmieder S; Müller-Tidow C
J Biol Chem; 2011 Aug; 286(32):28210-22. PubMed ID: 21540187
[TBL] [Abstract][Full Text] [Related]
2. The inhibitor of growth protein 5 (ING5) depends on INCA1 as a co-factor for its antiproliferative effects.
Zhang F; Bäumer N; Rode M; Ji P; Zhang T; Berdel WE; Müller-Tidow C
PLoS One; 2011; 6(7):e21505. PubMed ID: 21750715
[TBL] [Abstract][Full Text] [Related]
3. Identification of interaction partners and substrates of the cyclin A1-CDK2 complex.
Diederichs S; Bäumer N; Ji P; Metzelder SK; Idos GE; Cauvet T; Wang W; Möller M; Pierschalski S; Gromoll J; Schrader MG; Koeffler HP; Berdel WE; Serve H; Müller-Tidow C
J Biol Chem; 2004 Aug; 279(32):33727-41. PubMed ID: 15159402
[TBL] [Abstract][Full Text] [Related]
4. Zinc finger protein HZF1 promotes K562 cell proliferation by interacting with and inhibiting INCA1.
Li XB; Chen J; Deng MJ; Wang F; Du ZW; Zhang JW
Mol Med Rep; 2011; 4(6):1131-7. PubMed ID: 21874239
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of leukemia-initiating cells is regulated by the CDK inhibitor Inca1.
Bäumer N; Bäumer S; Berkenfeld F; Stehling M; Köhler G; Berdel WE; Müller-Tidow C; Tschanter P
PLoS One; 2014; 9(12):e115578. PubMed ID: 25525809
[TBL] [Abstract][Full Text] [Related]
7. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
Shimizu T; Awai N; Takeda K
Oncogene; 2000 Sep; 19(40):4640-6. PubMed ID: 11030153
[TBL] [Abstract][Full Text] [Related]
8. miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2.
Lin Y; Li D; Liang Q; Liu S; Zuo X; Li L; Sun X; Li W; Guo M; Huang Z
J Biol Chem; 2015 Jan; 290(3):1818-28. PubMed ID: 25451924
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
10. Cyclin E-CDK2 is a regulator of p27Kip1.
Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
[TBL] [Abstract][Full Text] [Related]
11. The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles.
Xie R; Medina R; Zhang Y; Hussain S; Colby J; Ghule P; Sundararajan S; Keeler M; Liu LJ; van der Deen M; Mitra P; Lian JB; Rivera-Perez JA; Jones SN; Stein JL; van Wijnen AJ; Stein GS
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12359-64. PubMed ID: 19590016
[TBL] [Abstract][Full Text] [Related]
12. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
13. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
[TBL] [Abstract][Full Text] [Related]
14. A novel testis protein, RSB-66, interacting with INCA1 (inhibitor of Cdk interacting with cyclin A1).
Chen X; Hu T; Liang G; Yang M; Zong S; Miao S; Koide SS; Wang L
Biochem Cell Biol; 2008 Aug; 86(4):345-51. PubMed ID: 18756329
[TBL] [Abstract][Full Text] [Related]
15. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
Sasca D; Szybinski J; Schüler A; Shah V; Heidelberger J; Haehnel PS; Dolnik A; Kriege O; Fehr EM; Gebhardt WH; Reid G; Scholl C; Theobald M; Bullinger L; Beli P; Kindler T
Blood; 2019 May; 133(21):2305-2319. PubMed ID: 30814062
[TBL] [Abstract][Full Text] [Related]
16. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase activating polypeptide anti-mitogenic signaling in cerebral cortical progenitors is regulated by p57Kip2-dependent CDK2 activity.
Carey RG; Li B; DiCicco-Bloom E
J Neurosci; 2002 Mar; 22(5):1583-91. PubMed ID: 11880488
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
Matsuoka M; Tani K; Asano S
Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells.
Savatier P; Lapillonne H; van Grunsven LA; Rudkin BB; Samarut J
Oncogene; 1996 Jan; 12(2):309-22. PubMed ID: 8570208
[TBL] [Abstract][Full Text] [Related]
20. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
